TCL Archive Drug Development: FDA Grants Breakthrough Therapy Designation to CTL019 In ALL July 11, 2014
TCL Archive BMS Execs Knew Of Flaws In ImClone Plan For C225 Prior To $2-Billion Licensing Deal June 21, 2002
TCL Archive Paul Marks To Retire As President, CEO Of Memorial Sloan-Kettering Cancer Center December 11, 1998